6/19/2025

Let’s dig into the relative performance of Penumbra (NYSE:PEN) and its peers as we unravel the now-completed Q1 medical devices & supplies - cardiology, neurology, vascular earnings season.

Source: Yahoo

6/19/2025

Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including ICU Medical (NASDAQ:ICUI) and its peers.

Source: Yahoo

6/10/2025

Over the last six months, ICU Medical’s shares have sunk to $136.25, producing a disappointing 14.9% loss while the S&P 500 was flat. This may have investors wondering how to approach the situation.

Source: Yahoo

6/4/2025

Smiths has not reported any serious injuries or deaths related to the issues, but the FDA sees a risk of harm.

Source: Yahoo

6/1/2025

NEW YORK, June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. . Such investors are advised to contact Danielle Peyton at...

Source: Finnhub

5/29/2025

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including Artivion (NYSE:AORT) and its peers.

Source: Yahoo

5/20/2025

A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Source: Yahoo

5/20/2025

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including Merit Medical Systems (NASDAQ:MMSI) and its peers.

Source: Yahoo

5/12/2025

A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains.

Source: Yahoo

5/10/2025

ICU Medical ( NASDAQ:ICUI ) First Quarter 2025 Results Key Financial Results Revenue: US$604.7m (up 6.7% from 1Q 2024...

Source: Yahoo

5/10/2025

ICU Medical, Inc. (NASDAQ:ICUI) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ETCompany ParticipantsJohn Mills – ICR, IRVivek Jain – Chief Executive...

Source: SeekingAlpha

5/9/2025

Medical device company ICU Medical (NASDAQ:ICUI) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 5.8% year on year to $599.5 million. Its non-GAAP profit of $1.72 per share was 34.4% above analysts’ consensus estimates.

Source: Yahoo

5/9/2025

The following slide deck was published by ICU Medical, Inc.

Source: SeekingAlpha

5/9/2025

ICU Medical Inc (ICUI) reports robust financial performance with a 10% revenue increase, while navigating potential tariff impacts and supply chain issues.

Source: Yahoo

5/9/2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

Source: Yahoo

5/8/2025

ICU Medical (ICUI) delivered earnings and revenue surprises of 39.84% and 5.54%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Source: Yahoo

5/8/2025

Medical device company ICU Medical (NASDAQ:ICUI) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 6.7% year on year to $604.7 million. Its non-GAAP profit of $1.72 per share was 34.4% above analysts’ consensus estimates.

Source: Yahoo

5/8/2025

ICUI) on Thursday reported a loss of $15.5 million in its first quarter. The San Clemente, California-based company said it had a loss of 63 cents per share. Earnings, adjusted for amortization costs and restructuring costs, were $1.72 per share.

Source: Yahoo

5/8/2025

ICU Medical Announces First Quarter 2025 Results May 8, 2025 SAN CLEMENTE, Calif., May 08, 2025 -- ICU Medical, Inc. , a leader in the development, manufacture and...

Source: Finnhub

5/8/2025

‌ICU Medical, Inc Q1 2025 Conference Call Presentation 1 May 8, 2025 ...

Source: Finnhub